PDMP & Data Surveillance
This session will feature two case studies in how states are utilizing more diverse data sources to respond to the opioid crisis. From Michigan, participants will learn how the Opioid Prescribing Engagement Network (Michigan OPEN) uses data to understand the factors contributing to the opioid epidemic and to inform the strategy to end the epidemic. Michigan OPEN was launched in October 2016 with support from the Michigan Department of Health and Human Services (MDHHS), Blue Cross Blue Shield of Michigan (BCBSM) Value Partnerships, and the Institute for Healthcare Policy and Innovation (IHPI) at the University of Michigan. The initiative’s central goals are to reduce the amount of opioids prescribed to surgical patients, eliminate prolonged postoperative opioid use, and reduce the unintended distribution of opioids into Michigan communities. Leveraging partnerships and collaborations has provided Michigan OPEN access to several data sources, such as the robust infrastructure of public and private insurance claim data from the Collaborative Quality Initiatives (CQI) program currently funded by BCBSM and genomic data collected through the University of Michigan’s Precision Health project. Michigan OPEN analyzes this data to track such things as opioid prescribing trends, health outcomes, and care utilization using health insurance claims. These analyses then inform the work of creating opioid prescribing recommendations for surgical procedures; examining the effectiveness of policies such as prescription drug monitoring program mandates and opioid prescribing limits; creating patient-facing educational materials; and devising and implementing a strategy to engage partners in hosting medication tack back events throughout the state of Michigan.
From Pennsylvania, participants will learn how the state developed emergency department (ED) surveillance for opioid ovedoses. With increasing naloxone distribution and usage in Pennsylvania, nonfatal opioid overdose surveillance is as important as fatal opioid overdose surveillance. The Pennsylvania Department of Health employs a vendor to host the Commonwealth’s syndromic surveillance system, EpiCenter. Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP) worked with the vendor and the Centers for Disease Control and Prevention (CDC) to develop three new classifiers to monitor drug overdose-related ED visits — Any Drug Overdoses, Any Opioid Overdoses, and Heroin Overdoses — as part of the work related to CDC’s Enhanced State Opioid Overdose Surveillance (ESOOS) grant. This presentation will summarize Pennsylvania’s overdose classifier case definitions, identified deficiencies, and details about an enhanced data collection project, which is an effort to improve the functioning of the Any Opioid and Heroin Overdose classifiers. Topics will include how this information is used, including weekly reports to the Commonwealth’s Incident Command Center, development of alerts, and how the alerts are used by the Incident Command Center to disseminate information to the appropriate county stakeholders. Currently, 162 of 172 hospital EDs are reporting. While Pennsylvania started to show a decrease in visits related to all three classifiers through the second half of 2017 and into the first quarter of 2018, an increase was again noted during the second quarter of 2018. This data is useful at both the state and county level for monitoring trends and allocating resources where they are needed.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB,* GA Post.
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.